期刊文献+

检测糖尿病肾病患者血清细胞因子的意义 被引量:5

The clinical significance of detection of serum levels of slCAM-1, IL-6, IL-8 and TNF-α in patients with diabetic nephritis
原文传递
导出
摘要 目的探讨2型糖尿病肾病患者血清可溶性细胞间粘附分子(sICAM-1)、白细胞介素-6(IL-6)、白细胞介素-8(IL-8)和肿瘤坏死因子-α(TNF-α)水平的变化及意义。方法选择2型糖尿病患者90例,根据尿白蛋白排泄率(UAER)分组:其中无白蛋白尿患者(DM组)24例,早期糖尿病肾病患者31例(DN1组),临床糖尿病肾病患者35例(DN2组),另外选择30例健康体检者作为对照(对照组)。采用酶联免疫吸附法(ELISA)测定各组血清sICAM-1、IL-6、IL-8和TNF-α水平并进行统计学分析。结果2型糖尿病肾病患者血清中sICAM-1、IL-6、IL-8和TNF-α水平高于正常对照组及DM组(t=5.68,5.12,4.87,4.96P〈0.05),DN2组血清中sICAM-1、IL-6、IL-8和TNF-α水平高于DN1组,组间比较差异有统计学意义(t=4.62,4.23,4.35,4.38,P〈0.05)。结论炎症因子sI-CAM-1、IL-6、IL-8和TNF-α可能参与了DN的病理生理过程,检测sICAM-1、IL-6、IL-8和TNF-α有助于DN患者病情及预后的判断。 Objective To investigate the changes of serum sICAM-1, IL-6, IL-8 and TNF-α levels in patients with diabetic nephritis and the clinical significance. Methods Ninety patients with type 2 diabetes were enrolled in this study. The patients were divided into three groups according to uri- nary albumin excretion rate(UAER) : 24 patients with normal UAER were in DM group, 31 patients with microalbuminuria were in DN1 group and 35 patients with clinical urine protein were in DN2 group. Thirty healthy subjects were choosed as control group. The serum levels of sICAM-1, IL-6, IL-8 and TNF-α were measured by ELISA and the results were analyzed statistically. Results The serum levels of sI- CAM-1, IL-6, IL-8 and TNF-α were significantly higher in patients with diabetic nephropathy than those in control group and DM group( t = 5.68,5.12,4. 87,4.96, P 〈 0. 05). The serum levels of sICAM-1, IL-6, IL-8 and TNF-α were significantly higher in DN2 group than those in DN1 group ( t =4. 62,4. 23, 4.35,4. 38, P 〈 0. 05 ). Conclusions sICAM-1, IL-6, IL-8 and TNF-α may participate in the patho- genesis of diabetic nephropathy. Monitoring the changes of their serum levels was helpful for the manage- ment and prognosis judgement of the disease.
出处 《中国实用医刊》 2012年第13期33-35,共3页 Chinese Journal of Practical Medicine
关键词 糖尿病肾病 可溶性细胞间黏附分子 白介素-6 白介素-8 肿瘤坏死因子-Α Diabetic nephritis Solubel intercellular adhesion molecule-1 ( sICAM-1 ) Interleu-kin-6 Interleukin-8 Tumor necrosis factor-α
  • 相关文献

参考文献10

二级参考文献44

  • 1何冰,韩萍,吕先科.2型糖尿病患者急性时相蛋白与糖尿病肾病的关系[J].中华内分泌代谢杂志,2003,19(4):260-262. 被引量:170
  • 2王汝霞,胡建廷,高聆,赵家军,张岫美.甘糖酯降低实验性糖尿病大鼠肾脏ICAM-1,VCAM-1表达Δ[J].中国海洋药物,2005,24(1):10-16. 被引量:12
  • 3孙培荣,石永兵.尿白蛋白/肌酐比值对诊断早期糖尿病肾病的价值[J].国际泌尿系统杂志,2006,26(4):573-575. 被引量:39
  • 4Kitagawa K, Matsumoto M, Sasaki T, et al. Involvement of ICAM-1 in the progression of atherosclerosis in APOE knockout mice [ J ]. Atherosclerosis, 2002,160 ( 2 ) : 305 -310.
  • 5[2]Aydin M,Ozkok E,Ozturk O,et al.Relationship between interleukin-8 and the oxidant-antioxidant system in end-stage renal failure patients.Exp Clin Transplant.2007,5(1):610-613.
  • 6[3]Wolf AM,Wolf D,Rumpold H,et al.The kinase inhibitor imatimib misylate inhibits production in vitro and prevents dependent acute hepatic inflammation.Proc Natl Acad Sci USA,2005,102 (38):13622-13627.
  • 7PICKUP J C,CROOK M A.Is type II diabetes mellitus a disease of innate immune system?[J].Diabetologia,1998,41(10):1241-1248.
  • 8PHILIP A,SUBRAMANIAN R,CHUNLING L,et al.Adipose tissue tumor necrosis factor and interleukin-6,expression in obesity and insulin resistance[J].Am J Physiol Endocrinol Metab,2001,280(5):E745-E751.
  • 9HRNCIAR J,GARBOR D,HRNCIAROVA M,et al.Relation between cytokine (TNF-alpha,IL-6 and 1)and homocysteine in android obesity and the phenomenon of insulin resistance syndromes[J].Vnitr Lek,1999,45(1):11-16.
  • 10BARBORA V,CHRISTIAN W,ROBERT S,et al.High white blood cell count is associated with a worsening of insulin sensitivity and predicts the development of type 2 diabetes[J].Diabetes,2002,51(2):455-461.

共引文献110

同被引文献44

  • 1Corry D B, Eslami P, Yamamoto K, et al.Uric acid stimulates vascular smooth muscle cell proliferation and oxidative stress via the vascular rennin-angiotensin system[J] .Hypertens, 2008, 26 ( 2 ) : 269-275.
  • 2李轶.史耀勋.糖尿病肾病患者ClIP、HbAle、mALB、TNF-α检测的临床价值[J].中国中医院现代远程教育,2011,9(14):91-92.
  • 3King DE,Mainous AG,Egan BM,et al.Use of statins pressure[J].Am J Hypertens,2007,20(9):937-941.
  • 4Hakim FA,Ptlueger A.Role of oxidative stress in diabetic kidneydisease[J].Med Sci Monit,2010,16(2):A37-48.
  • 5Stehouwer CDA,Schaper NC.The pathogenesis of vascular com-plications of diabetes me] litus:one voice or many[J].Eur J ClinInvest,1996,26(7):535-543.
  • 6Fujii M,Inoguchi T,Maeda Y,et,al.Pitavastatinameli orates al-bum in uria and renal mesangial expansion by down regulatingN0X4 in db /db mice[J].Kidney Int,2007,72(4):473-480.
  • 7Campese VM,Park J.HMG-CoA reductase inhibitors and the kid-ney[J].Kidney Int,2007,71(12):1215-1222.
  • 8Jones PH,Davidson MH,Stein EA,et al.Comparison ofthe effica-cy and safety of rosuvastatin versus atorvastatin,simvastatin,andpravastatin across doses(STELLAR Trial)[J].Am J Cardiol,2003,92(1):152-160.
  • 9SATOH H,NGUYEN M T,MILESPD,etal.AdenovirusGmediatedchronic“hyperGresistinemia”leadstoinvivoinsulinresistanceinnormalrats[J].TheJournalofClinicalInvestigaGtion,2004,114(2):224-231.
  • 10Libby P. Ridker PM,Maseri A. Inflammation and atherosclerosis[J]. Circulation,2006,105(9): 1135-1143.

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部